ArticleBreast cancer research : BCR2025

NOTCH1 inhibition enhances immunogenicity and sensitizes triple-negative breast cancer to immune checkpoint inhibitors.

Ying Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.